美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Lineage

45.62

+0.91002.04%

盤後：45.620.00000.00%19:04 EDT

成交量：94.45萬

成交額：4,292.77萬

市值：104.28億

市盈率：-14.36

高：45.80

開：44.69

低：44.53

收：44.71

資料載入中...

總覽公司新聞資訊公告

Lineage Cell Therapeutics 2024年第四季度GAAP每股收益$(0.02) 超過預期$(0.03)，銷售額$2.900百萬超預期$1.621百萬

Scotiabank：維持Lineage(LINE.US)評級，由跑贏大盤調整至跑贏大盤評級, 目標價由73.00美元調整至74.00美元。

Lineage Cell Therapeutics, Inc.盤中異動早盤快速上漲7.06%

Web3遊戲Bombie在LINE平台ARPPU突破194美元，月新增141萬用户

Bombie ARPPU達194美元，超越《英雄聯盟》等Web2遊戲

Lineage Cell Therapeutics, Inc.盤中異動股價大漲5.53%報0.548美元

美國研究綜述-坎貝爾、Veeva Systems、Zscaler

Lineage Cell Therapeutics, Inc.盤中異動股價大漲5.02%

Lineage Cell Therapeutics, Inc.盤中異動早盤股價大跌5.24%報0.532美元

Lineage Cell Therapeutics, Inc.盤中異動股價大跌7.13%報0.582美元

異動解讀 | 機構下調目標價,Lineage股價盤中大漲5.21%

Lineage, Inc.盤中異動快速上漲5.16%

Baird：維持Lineage(LINE.US)評級，由優於大市調整至優於大市評級, 目標價由76.00美元調整至70.00美元。

Piper Sandler：維持Lineage(LINE.US)評級，由增持調整至增持評級, 目標價由90.00美元調整至75.00美元。

Lineage Inc 報告截至 12 月 31 日的季度業績 - 收益摘要

Lineage 第四季度 GAAP 每股盈餘 $(0.33) 未達 $0.09 預期，銷售額 $13.4 億持平

Lineage Inc 預計每股收益9美分 - 財報前瞻

Lineage Cell Therapeutics, Inc.盤中異動早盤股價大漲5.04%報0.730美元

Lineage Cell Therapeutics, Inc.盤中異動股價大漲5.26%

Lineage Cell Therapeutics, Inc.盤中異動早盤股價大跌5.08%報0.655美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/LINE/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LINE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LINE\",,,,,undefined,":{"symbol":"LINE","market":"US","secType":"STK","nameCN":"Lineage","latestPrice":45.62,"timestamp":1746820800000,"preClose":44.71,"halted":0,"volume":944507,"hourTrading":{"tag":"盘后","latestPrice":45.62,"preClose":45.62,"latestTime":"19:04 EDT","volume":8544,"amount":389776.68,"timestamp":1746831862869},"delay":0,"floatShares":70869467,"shares":228590171,"eps":-3.176192,"marketStatus":"休市中","change":0.91,"latestTime":"05-09 16:00:00 EDT","open":44.69,"high":45.8,"low":44.53,"amount":42927701.47395,"amplitude":0.028405,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.176192,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":7,"adr":0,"listingDate":1721880000000,"exchange":"NASDAQ","adjPreClose":44.71,"dividendRate":0.031456,"preHourTrading":{"tag":"盘前","latestPrice":45.5,"preClose":44.71,"latestTime":"08:26 EDT","volume":254,"amount":11186.65784,"timestamp":1746793582767},"postHourTrading":{"tag":"盘后","latestPrice":45.62,"preClose":45.62,"latestTime":"19:04 EDT","volume":8544,"amount":389776.68,"timestamp":1746831862869},"volumeRatio":0.5844995377263563,"impliedVol":0.315,"impliedVolPercentile":0.1421},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LINE\",,,,,undefined,":{"symbol":"LINE","floatShares":70869467,"roa":"0.50%","roe":"-9.07%","lyrEps":-3.696335,"volumeRatio":0.5844995377263563,"shares":228590171,"dividePrice":1.435,"high":45.8,"amplitude":0.028405,"preClose":44.71,"low":44.53,"week52Low":42.05,"pbRate":"1.21","psRate":"1.97","week52High":89.85,"institutionHeld":0.1784,"latestPrice":45.62,"eps":-3.176192,"divideRate":0.031456,"volume":944507,"delay":0,"ttmEps":-3.176192,"open":44.69,"prevYearClose":58.57,"prevWeekClose":45.28,"prevMonthClose":48.23,"prevQuarterClose":58.63,"fiveDayClose":45.28,"twentyDayClose":52.22,"sixtyDayClose":56.55},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LINE\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1166565406","title":"Lineage Cell Therapeutics 2024年第四季度GAAP每股收益$(0.02) 超過預期$(0.03)，銷售額$2.900百萬 超預期$1.621百萬","url":"https://stock-news.laohu8.com/highlight/detail?id=1166565406","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166565406?lang=zh_tw&edition=fundamental","pubTime":"2025-03-11 04:08","pubTimestamp":1741637306,"startTime":"0","endTime":"0","summary":"公司报告季度销售额$2.900百万，超过了分析师共识预估的$1.621百万，提高了78.88%。与去年同期的销售额$2.100百万相比，这一数字增长了38.10%。以上内容来自Benzinga Earnings专栏，原文如下：$Lineage$ Cell $Therapeutics$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 33.33 percent. This is a 33.33 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $2.900 million which beat the analyst consensus estimate of $1.621 million by 78.88 percent.  This is a 38.10 percent","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LCTX","LINE","LENZ"],"gpt_icon":0},{"id":"2518220660","title":"Scotiabank：維持Lineage(LINE.US)評級，由跑贏大盤調整至跑贏大盤評級, 目標價由73.00美元調整至74.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518220660","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518220660?lang=zh_tw&edition=fundamental","pubTime":"2025-03-11 02:02","pubTimestamp":1741629758,"startTime":"0","endTime":"0","summary":"Scotiabank：维持Lineage(LINE.US)评级，由跑赢大盘调整至跑赢大盘评级, 目标价由73.00美元调整至74.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11020248641749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LINE"],"gpt_icon":0},{"id":"2518527621","title":"Lineage Cell Therapeutics, Inc.盤中異動 早盤快速上漲7.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518527621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518527621?lang=zh_tw&edition=fundamental","pubTime":"2025-03-10 21:39","pubTimestamp":1741613947,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时39分，Lineage Cell Therapeutics, Inc.股票出现波动，股价急速上涨7.06%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Trevi Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Scisparc Ltd.、Dogwood Therapeutics, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为487.59%、74.68%、56.14%，振幅较大的相关个股有Scisparc Ltd.、Impact Biomedical, Inc.、Trevi Therapeutics, Inc.，振幅分别为34.57%、28.59%、25.35%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213908964037cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213908964037cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","LINE","LCTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2517443559","title":"Web3遊戲Bombie在LINE平台ARPPU突破194美元，月新增141萬用户","url":"https://stock-news.laohu8.com/highlight/detail?id=2517443559","media":"世链财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517443559?lang=zh_tw&edition=fundamental","pubTime":"2025-03-08 17:57","pubTimestamp":1741427820,"startTime":"0","endTime":"0","summary":"3 月 8 日，在白宫加密货币政策的推动下，Web3 游戏 Bombie 迎来爆发式增长。其 LINE 平台 ARPPU 突破 194 美元，一个月内新增 141 万用户，超越《英雄联盟》《守望先锋》等 Web2 游戏巨头。同时，Bombie 在 Telegram 平台的 ARPPU 已达 80 美","market":"hk","thumbnail":"https://m.shilian.com/assets/addons/cms/img/noimage/92.jpg","type":0,"news_type":0,"thumbnails":["https://m.shilian.com/assets/addons/cms/img/noimage/92.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://m.shilian.com//kuaixun/788431.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"shilian_live","symbols":["GBTC","TON.USD.HKCC","SNX.USD.CC","LINE","HODL","BK4585","ATOM.USD.HKCC","LINK.USD.HKCC","APT.USD.HKCC","COMP.USD.CC","IBIT","BK4594","DEFI","BK4601","BRRR","EZBC","AVAX.USD.HKCC","AVAX.USD.CC","BITO","BK4588","DYDX.USD.HKCC","FBTC","USDT.USD.CC","DOT.USD.CC","LTC.USD.HKCC","SNX.USD.HKCC","APT.USD.CC","DOT.USD.HKCC","MKR.USD.CC","UNI.USD.HKCC","BTCW","VBTC.AU","LDO.USD.HKCC","COMP.USD.HKCC","TON.USD.CC","UNI.USD.CC","BK4224","BTCO"],"gpt_icon":0},{"id":"2517641757","title":"Bombie ARPPU達194美元，超越《英雄聯盟》等Web2遊戲","url":"https://stock-news.laohu8.com/highlight/detail?id=2517641757","media":"Odaily","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517641757?lang=zh_tw&edition=fundamental","pubTime":"2025-03-08 16:57","pubTimestamp":1741424273,"startTime":"0","endTime":"0","summary":"Odaily星球日报讯 Web3 游戏 Bombie 的 LINE 平台 ARPPU 突破 194 美元，一个月内新增 141 万用户，超越《英雄联盟》《守望先锋》等 Web2 游戏巨头。同时，Bombie 在 Telegram 平台的 ARPPU 已达 80 美元，用户规模突破 964 万，双平台游戏总收入已超 1800 万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.odaily.news/newsflash/422421?source=share","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"odaily_live","symbols":["LINE","BK4224"],"gpt_icon":0},{"id":"2517160017","title":"Lineage Cell Therapeutics, Inc.盤中異動 股價大漲5.53%報0.548美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517160017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517160017?lang=zh_tw&edition=fundamental","pubTime":"2025-03-07 00:51","pubTimestamp":1741279881,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日00时51分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速拉升5.53%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307005121989ece5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307005121989ece5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","BK4224","LENZ","BK4139","LCTX"],"gpt_icon":0},{"id":"2517189413","title":"美國研究綜述-坎貝爾、Veeva Systems、Zscaler","url":"https://stock-news.laohu8.com/highlight/detail?id=2517189413","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517189413?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 15:18","pubTimestamp":1741245489,"startTime":"0","endTime":"0","summary":"美国研究综述-坎贝尔、Veeva Systems、Zscaler路透社3月6日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括金宝仕、Veeva Systems 和 Zscaler。* Veeva Systems Inc VEEV.N：TD Cowen将目标价从250.00美元上调至261.00美元 * Zscaler Inc ZS.O：加拿大皇家银行将目标价从230美元上调至250美元以下是路透社周四报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nL3S3PP0JN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4224","LU1923622291.USD","BK4607","LU2272731782.SGD","LU0130518102.USD","BK4528","CAG","LU0353189763.USD","CPB","MDB","BK4167","BK4097","LU1989764664.SGD","LU0058720904.USD","LU1989764748.USD","BK4082","ZS","LU1861220033.SGD","LU2087625088.SGD","LU2272731600.USD","BK4166","EPR","NVST","BK4524","LU0823434740.USD","SLM","LU2125909759.SGD","LU2517655291.USD","LU0823434583.USD","LU1992135399.USD","LU2517655374.HKD","BK4504","LU0130103400.USD","LU1992135472.HKD","LU1720051017.SGD","LU0266013472.USD","BK4588","BK4534","LU2517655028.SGD","BK4608","LU2286300806.USD","VEEV","BK4116","BK4234","LINE","BK4212","LU0719512351.SGD","LU0648000940.SGD","LU2357305700.SGD","CMPO"],"gpt_icon":0},{"id":"2517028306","title":"Lineage Cell Therapeutics, Inc.盤中異動 股價大漲5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517028306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517028306?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 01:32","pubTimestamp":1741109577,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日01时32分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅上涨5.02%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305013257a25f3654&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305013257a25f3654&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LINE","BK4224","LENZ","LCTX"],"gpt_icon":0},{"id":"2516344637","title":"Lineage Cell Therapeutics, Inc.盤中異動 早盤股價大跌5.24%報0.532美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516344637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516344637?lang=zh_tw&edition=fundamental","pubTime":"2025-03-03 23:05","pubTimestamp":1741014302,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时05分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅下挫5.24%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Entero Therapeutics Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1039.63%、125.32%、100.95%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为163.15%、70.53%、48.34%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230502a25d4a2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230502a25d4a2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","BK4224","LCTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2514833037","title":"Lineage Cell Therapeutics, Inc.盤中異動 股價大跌7.13%報0.582美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514833037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514833037?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 04:48","pubTimestamp":1740689324,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时48分，Lineage Cell Therapeutics, Inc.股票出现异动，股价快速跳水7.13%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.49%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1949.46%、414.29%、197.51%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228044844abdfc11f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228044844abdfc11f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","LCTX","LENZ","BK4139","LINE"],"gpt_icon":0},{"id":"1123042009","title":"異動解讀 | 機構下調目標價,Lineage股價盤中大漲5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=1123042009","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123042009?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 02:46","pubTimestamp":1740682013,"startTime":"0","endTime":"0","summary":"Lineage(LINE.US)今日盘中股价出现大幅波动,最高上涨5.21%。引起市场关注的原因是,分析机构Piper Sandler对该公司的投资评级进行了调整。\n\nPiper Sandler维持了Lineage的\"增持\"评级,但将目标价从90美元大幅下调至75美元。股价波动可能与市场对该调整的反应有关。\n\nLineage是一家房地产投资信托公司,为客户提供端到端的供应链服务,包括冷藏仓储、运输代理等。机构调低目标价或许意味着对该公司前景的担忧,但仍维持增持评级,也说明该公司未来仍有较大增长空间。具体原因有待进一步观察和分析。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 机构下调目标价,Lineage股价盘中大涨5.21%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["LINE"],"gpt_icon":0},{"id":"2514336753","title":"Lineage, Inc.盤中異動 快速上漲5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514336753","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514336753?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 02:40","pubTimestamp":1740681645,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日02时40分，Lineage, Inc.股票出现波动，股价急速上涨5.16%。Lineage, Inc.股票所在的房地产信托行业中，整体涨幅为0.52%。其相关个股中，Generation Income Properties Inc C/Wts 、Medical Properties Trust, Inc.、Postal Realty Trust, Inc.涨幅较大，Wheeler Real Estate Investment Trust, Inc.、Orchid Island Capital, Inc.、Medical Properties Trust, Inc.较为活跃，换手率分别为7.83%、2.84%、2.78%，振幅较大的相关个股有Generation Income Properties Inc C/Wts 、Service Properties Trust - Shares Of Beneficial Interest、Power Reit ，振幅分别为192.70%、17.29%、14.40%。Lineage, Inc.公司简介：Lineage Inc是一家房地产投资信托。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022802404598953ed2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022802404598953ed2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","BK4224"],"gpt_icon":0},{"id":"2514836593","title":"Baird：維持Lineage(LINE.US)評級，由優於大市調整至優於大市評級, 目標價由76.00美元調整至70.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514836593","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514836593?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 22:22","pubTimestamp":1740666171,"startTime":"0","endTime":"0","summary":"Baird：维持Lineage(LINE.US)评级，由优于大市调整至优于大市评级, 目标价由76.00美元调整至70.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/27222248438483.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LINE"],"gpt_icon":0},{"id":"2514526388","title":"Piper Sandler：維持Lineage(LINE.US)評級，由增持調整至增持評級, 目標價由90.00美元調整至75.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514526388","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514526388?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 22:06","pubTimestamp":1740665207,"startTime":"0","endTime":"0","summary":"Piper Sandler：维持Lineage(LINE.US)评级，由增持调整至增持评级, 目标价由90.00美元调整至75.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/27220648438141.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LINE"],"gpt_icon":0},{"id":"2514855467","title":"Lineage Inc 報告截至 12 月 31 日的季度業績 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2514855467","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514855467?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 22:32","pubTimestamp":1740580339,"startTime":"0","endTime":"0","summary":"Lineage Inc 报告截至 12 月 31 日的季度业绩 - 收益摘要Lineage Inc LINE.OQ报告，截至12月31日的季度调整后每股亏损33美分。华尔街预期为每股收益 3 美分至 14 美分。Lineage Inc公布的本季度每股收益为亏损33美分。Lineage Inc 本季度股价下跌了 4.6%。华尔街对 Lineage Inc 的 12 个月目标价中位数为 78.50 美元。)季度末预计 实际超过、达到、未达到2024 年 12 月 31 日 0.720.83未达2024 年 9 月 30 日 0.780.90节拍2024 年 6 月 30 日 0.800.84节拍(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nL3T3PH1BV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4224","LINE"],"gpt_icon":0},{"id":"1108635388","title":"Lineage 第四季度 GAAP 每股盈餘 $(0.33) 未達 $0.09 預期，銷售額 $13.4 億持平","url":"https://stock-news.laohu8.com/highlight/detail?id=1108635388","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108635388?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 19:31","pubTimestamp":1740569516,"startTime":"0","endTime":"0","summary":"Lineage  公布季度亏损每股 $，未达到分析师普遍预期的 $0.09，差了 466.67%。这是相较于去年同期每股 $ 的亏损增长了 23.26%。公司报告季度销售额为 $13.4 亿，符合分析师普遍预期。以上内容来自Benzinga Earnings专栏，原文如下：$Lineage$  reported quarterly losses of $ per share which missed the analyst consensus estimate of $0.09 by 466.67 percent. This is a 23.26 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $1.34 billion which met the analyst consensus estimate.  This is a 0.37 percent increase over sales of $1.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Lineage 第四季度 GAAP 每股盈余 $(0.33) 未达 $0.09 预期，销售额 $13.4 亿持平","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LINE"],"gpt_icon":0},{"id":"2513724679","title":"Lineage Inc 預計每股收益9美分 - 財報前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2513724679","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513724679?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 22:11","pubTimestamp":1740406269,"startTime":"0","endTime":"0","summary":"Lineage Inc 预计每股收益9美分 - 财报前瞻Lineage Inc LINE.OQ LINE.O 预计将于 2 月 26 日公布截至 2024 年 12 月 31 日的财报。根据 LSEG 的数据，9 位分析师的平均预期显示，这家总部位于密歇根州诺维市的公司预计将实现营收 13.36 亿美元。LSEG 分析师对 Lineage Inc 的平均预期为每股收益 9 美分。华尔街对 Lineage Inc 的 12 个月目标价中位数为 78.50 美元，高于其上次收盘价 53.88 美元。2月24日 - 以前季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nL3S3PF0ZA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LINE"],"gpt_icon":0},{"id":"2512651851","title":"Lineage Cell Therapeutics, Inc.盤中異動 早盤股價大漲5.04%報0.730美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512651851","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512651851?lang=zh_tw&edition=fundamental","pubTime":"2025-02-18 22:41","pubTimestamp":1739889678,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时41分，Lineage Cell Therapeutics, Inc.股票出现波动，股价大幅拉升5.04%。截至发稿，该股报0.730美元/股，成交量20.4838万股，换手率0.09%，振幅3.25%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218224118abd3b177&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218224118abd3b177&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","LCTX","BK4224","LINE"],"gpt_icon":0},{"id":"2511522318","title":"Lineage Cell Therapeutics, Inc.盤中異動 股價大漲5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511522318","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511522318?lang=zh_tw&edition=fundamental","pubTime":"2025-02-13 23:51","pubTimestamp":1739461899,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时51分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅上涨5.26%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Edesa Biotech, Inc.、Pliant Therapeutics, Inc.、Dominari Holdings Inc.涨幅较大，Edesa Biotech, Inc.、Tc Biopharm  Plc、Genprex, Inc.较为活跃，换手率分别为2568.57%、1156.53%、159.27%，振幅较大的相关个股有Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为95.15%、92.30%、42.61%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021323514098843c1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021323514098843c1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","BK4139","LENZ","BK4224","LINE"],"gpt_icon":0},{"id":"2508463725","title":"Lineage Cell Therapeutics, Inc.盤中異動 早盤股價大跌5.08%報0.655美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508463725","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508463725?lang=zh_tw&edition=fundamental","pubTime":"2025-02-04 23:30","pubTimestamp":1738683041,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日23时30分，Lineage Cell Therapeutics, Inc.股票出现波动，股价大幅下跌5.08%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。其相关个股中，Azitra Inc、Evaxion Biotech As、Nutriband Inc C/Wts 涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为1502.80%、880.18%、223.05%，振幅较大的相关个股有Azitra Inc、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Viracta Therapeutics, Inc.，振幅分别为64.17%、49.88%、44.22%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204233041a2393498&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204233041a2393498&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","BK4224","LCTX","BK4139","LENZ"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":4,"totalSize":134,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LINE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-04-30","symbol":"LINE","fiscalQuarterEnding":"2025/03","expectedEps":0.67,"name":null,"time":"盤前","type":"earning","dateTimestamp":1745985600000,"reportTimeType":"pre","actualEps":0.86},{"date":"2025-03-31","symbol":"LINE","amount":0.5275,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-31","defaultRemindTime":1743427800000,"name":"Lineage","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-21","payableDate":"2025-03-31","currency":"USD","dateTimestamp":1743393600000,"payDate":"2025-04-21"},{"market":"US","date":"2025-02-26","symbol":"LINE","fiscalQuarterEnding":"2024/12","expectedEps":0.68,"name":null,"time":"盤前","type":"earning","dateTimestamp":1740546000000,"reportTimeType":"pre","actualEps":0.83},{"date":"2024-12-31","symbol":"LINE","amount":0.5275,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-31","defaultRemindTime":1735655400000,"name":"Lineage","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-01-21","payableDate":"2024-12-31","currency":"USD","dateTimestamp":1735621200000,"payDate":"2025-01-21"},{"market":"US","date":"2024-11-06","symbol":"LINE","fiscalQuarterEnding":"2024/09","expectedEps":0.78,"name":null,"time":"盤前","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"pre","actualEps":0.9}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LINE\",market:\"US\",,,undefined,":[{"executeDate":"2024-09-30","recordDate":"2024-09-30","paymentDate":"2024-10-21","value":0.38,"currency":"USD"},{"executeDate":"2024-12-31","recordDate":"2024-12-31","paymentDate":"2025-01-21","value":0.5275,"currency":"USD"},{"executeDate":"2025-03-31","recordDate":"2025-03-31","paymentDate":"2025-04-21","value":0.5275,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LINE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.0556,"buy":0.4444,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4444,"analysts":18,"updateTime":1746590400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LINE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LINE","date":"2025-05-08","current":-16.096558,"percent":0.994737,"low":-150.084638,"twenty":-90.639401,"median":-21.446806,"eighty":-19.908189,"high":-16.037945,"avg":-49.715972,"sd":42.136085,"marketCap":10044252113},"quantilePoints":[{"date":"2024-08-02","current":-146.000818,"twenty":-146.000818,"median":-146.000818,"eighty":-146.000818,"marketCap":19680910257},{"date":"2024-08-09","current":-150.084638,"twenty":-146.017763,"median":-145.856783,"eighty":-145.221334,"marketCap":20231409255},{"date":"2024-08-16","current":-142.88288,"twenty":-146.017763,"median":-145.492459,"eighty":-142.88288,"marketCap":19260612266},{"date":"2024-08-23","current":-142.59261,"twenty":-146.509177,"median":-145.602603,"eighty":-142.59261,"marketCap":19221483852},{"date":"2024-08-30","current":-95.803712,"twenty":-146.271943,"median":-143.713201,"eighty":-98.730155,"marketCap":19007456432},{"date":"2024-09-06","current":-95.402043,"twenty":-146.068599,"median":-142.59261,"eighty":-96.597868,"marketCap":18927765371},{"date":"2024-09-13","current":-94.621658,"twenty":-146.004207,"median":-142.327922,"eighty":-95.080709,"marketCap":18772937025},{"date":"2024-09-20","current":-94.254418,"twenty":-145.770362,"median":-98.489154,"eighty":-94.64002,"marketCap":18700076626},{"date":"2024-09-27","current":-89.824587,"twenty":-145.536517,"median":-96.48081,"eighty":-93.930788,"marketCap":17821198071},{"date":"2024-10-04","current":-88.080197,"twenty":-145.275559,"median":-95.539758,"eighty":-92.831364,"marketCap":17475111178},{"date":"2024-10-11","current":-84.912753,"twenty":-144.014828,"median":-95.063494,"eighty":-89.930169,"marketCap":16846690242},{"date":"2024-10-18","current":-87.712958,"twenty":-143.048944,"median":-94.644611,"eighty":-88.075607,"marketCap":17402250780},{"date":"2024-10-25","current":-89.158965,"twenty":-142.650664,"median":-94.409347,"eighty":-88.190369,"marketCap":17689138599},{"date":"2024-10-31","current":-86.301379,"twenty":-142.563428,"median":-93.892916,"eighty":-87.898873,"marketCap":17122193624},{"date":"2024-11-08","current":-24.107959,"twenty":-142.432135,"median":-92.969079,"eighty":-87.45589,"marketCap":15535169004},{"date":"2024-11-15","current":-22.358645,"twenty":-142.321991,"median":-92.056717,"eighty":-86.491885,"marketCap":14407910854},{"date":"2024-11-22","current":-22.291364,"twenty":-116.1574,"median":-90.604972,"eighty":-85.11244,"marketCap":14364554771},{"date":"2024-11-29","current":-22.457796,"twenty":-98.633755,"median":-89.84754,"eighty":-83.062782,"marketCap":14471804028},{"date":"2024-12-06","current":-22.273658,"twenty":-98.328486,"median":-89.399966,"eighty":-23.717728,"marketCap":14353145276},{"date":"2024-12-13","current":-22.082438,"twenty":-97.522854,"median":-88.367104,"eighty":-22.894771,"marketCap":14229922725},{"date":"2024-12-20","current":-20.148985,"twenty":-96.51983,"median":-88.068721,"eighty":-22.516579,"marketCap":12984005822},{"date":"2024-12-27","current":-20.846586,"twenty":-96.189314,"median":-87.867887,"eighty":-22.462754,"marketCap":13433539942},{"date":"2025-01-03","current":-20.665989,"twenty":-95.803712,"median":-87.603934,"eighty":-22.358645,"marketCap":13317163089},{"date":"2025-01-10","current":-19.996717,"twenty":-95.592549,"median":-87.449004,"eighty":-22.235414,"marketCap":12885884161},{"date":"2025-01-17","current":-20.329582,"twenty":-95.429586,"median":-87.127669,"eighty":-22.065441,"marketCap":13100382675},{"date":"2025-01-24","current":-21.186534,"twenty":-95.216128,"median":-86.381713,"eighty":-21.592346,"marketCap":13652602255},{"date":"2025-01-31","current":-21.229027,"twenty":-95.057756,"median":-85.698876,"eighty":-21.234693,"marketCap":13679985044},{"date":"2025-02-07","current":-20.619954,"twenty":-94.91086,"median":-83.983177,"eighty":-21.199282,"marketCap":13287498401},{"date":"2025-02-14","current":-19.908189,"twenty":-94.718059,"median":-53.523399,"eighty":-20.89262,"marketCap":12828836683},{"date":"2025-02-21","current":-19.369938,"twenty":-94.63543,"median":-23.897456,"eighty":-20.823215,"marketCap":12481988022},{"date":"2025-02-28","current":-20.503397,"twenty":-94.598706,"median":-23.236843,"eighty":-20.740352,"marketCap":13614255869},{"date":"2025-03-07","current":-20.963916,"twenty":-94.440333,"median":-22.902207,"eighty":-20.736811,"marketCap":13920040363},{"date":"2025-03-14","current":-19.513626,"twenty":-94.135065,"median":-22.613606,"eighty":-20.682059,"marketCap":12957047406},{"date":"2025-03-21","current":-20.723347,"twenty":-93.90554,"median":-22.503831,"eighty":-20.657101,"marketCap":13760302194},{"date":"2025-03-28","current":-20.579005,"twenty":-93.783892,"median":-22.457796,"eighty":-20.605323,"marketCap":13664459294},{"date":"2025-04-04","current":-19.386467,"twenty":-93.416653,"median":-22.388745,"eighty":-20.521213,"marketCap":12872614375},{"date":"2025-04-11","current":-17.946487,"twenty":-92.941536,"median":-22.273658,"eighty":-20.34233,"marketCap":11916467340},{"date":"2025-04-17","current":-18.86237,"twenty":-92.831364,"median":-22.224082,"eighty":-20.27245,"marketCap":12524613365},{"date":"2025-04-25","current":-19.376157,"twenty":-92.356247,"median":-22.119619,"eighty":-20.124586,"marketCap":12865768453},{"date":"2025-05-02","current":-17.298122,"twenty":-91.37388,"median":-21.962039,"eighty":-20.00357,"marketCap":10794027874},{"date":"2025-05-08","current":-16.096558,"twenty":-90.639401,"median":-21.446806,"eighty":-19.908189,"marketCap":10044252113}],"updateTime":1746856414134}}}